These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18606904)

  • 1. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder.
    Matsui H; Ando K; Kawarazaki H; Nagae A; Fujita M; Shimosawa T; Nagase M; Fujita T
    Hypertension; 2008 Aug; 52(2):287-94. PubMed ID: 18606904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
    Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
    Nagase M; Yoshida S; Shibata S; Nagase T; Gotoda T; Ando K; Fujita T
    J Am Soc Nephrol; 2006 Dec; 17(12):3438-46. PubMed ID: 17082236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High salt intake accelerated cardiac remodeling in spontaneously hypertensive rats: time window of left ventricular functional transition and its relation to salt-loading doses.
    Gao F; Han ZQ; Zhou X; Shi R; Dong Y; Jiang TM; Li YM
    Clin Exp Hypertens; 2011; 33(7):492-9. PubMed ID: 21529316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-phosphorus/zinc-free diet aggravates hypertension and cardiac dysfunction in a rat model of the metabolic syndrome.
    Suzuki Y; Mitsushima S; Kato A; Yamaguchi T; Ichihara S
    Cardiovasc Pathol; 2014; 23(1):43-9. PubMed ID: 23932324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
    Susic D; Varagic J; Frohlich ED
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1177-81. PubMed ID: 20118410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
    Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
    Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction.
    Matsui H; Shimosawa T; Uetake Y; Wang H; Ogura S; Kaneko T; Liu J; Ando K; Fujita T
    Hypertension; 2006 Aug; 48(2):225-31. PubMed ID: 16818802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension.
    Takeda Y
    Hypertens Res; 2009 May; 32(5):321-4. PubMed ID: 19300447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR.
    Susic D; Varagic J; Ahn J; Matavelli L; Frohlich ED
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H175-9. PubMed ID: 16905598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess.
    Susic D; Frohlich ED
    J Am Soc Hypertens; 2014 May; 8(5):297-302. PubMed ID: 24726099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats.
    Urabe A; Izumi T; Abe Y; Taniguchi I; Mochizuki S
    Hypertens Res; 2006 Aug; 29(8):627-34. PubMed ID: 17137219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in adipocytokines and cardiac function in a rat model of the metabolic syndrome.
    Yamaguchi T; Kitamori K; Ichihara G; Suzuki Y; Ochiai M; Yamada Y; Tada-Oikawa S; Tsuchikura S; Yamori Y; Ichihara S
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):443-8. PubMed ID: 23659633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.
    Bender SB; DeMarco VG; Padilla J; Jenkins NT; Habibi J; Garro M; Pulakat L; Aroor AR; Jaffe IZ; Sowers JR
    Hypertension; 2015 May; 65(5):1082-8. PubMed ID: 25712719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.